|SEPT 17||SEPT 18||SEPT 19||SEPT 20|
|9:00 – 9:40||Keynote Speaker 1||Keynote Speaker3||Keynote Speaker 5|
|9:45 – 10:25||3 short talks||3 short talks||3 short talks|
|10:30 – 11:10||Coffee break||Coffee break||Coffee break|
|11:15 – 11:55||3 short talks||3 short talks||3 short talks|
|12:00 – 12:45||Keynote Speaker 2||Keynote Speaker 4||Keynote Speaker 6|
|13:00 – 14:00||Lunch||Lunch||Lunch|
|14:00 – 17:00||Free time||Video shooting||2h trip + free time|
|17:00 – 18:30||ARRIVALS||Workshop 1||Workshop 2||Workshop 4|
|18:30 – 20:00||ARRIVALS||Barbecue||Workshop 3||Workshop 5|
|20:00 – 21:00||ARRIVALS||Cremat||Free time||Free time|
|21:00 – 22:00||Dinner||Sky watching||Dinner||Dinner|
All MECHANO·CONTROL consortium members will be attending the summer school and will be giving some of the whorkshops:
- Aránzazu del Campo (Leibniz-Institut für Neue Materialien, INM)
- Sergi Garcia-Manyes (King’s College London, KCL)
- Pere Roca-Cusachs and Xavier Trepat (Institute for Bioengineering of Catalonia, IBEC)
- Patrick Derksen and Johan de Rooij (University Medical Center Utrecht, UMCU)
- Marino Arroyo (Universitat Politècnica de Catalunya, UPC)
- and the companies NovioCell and Mind the Byte.
8th May 2019
Is now closed, for further information contact with email@example.com
The MECHANO·CONTROL project is focused on the
mechanical control of biological function. Mechanical forces transmitted through specific molecular bonds drive biological function, and their understanding and control hold an uncharted potential in oncology,
regenerative medicine and biomaterial design.
MECHANO·CONTROL proposes to address this challenge by building an interdisciplinary research community with the aim of understanding and controlling cellular mechanics from the molecular to the organism scale.
At all stages and scales of the project, it will integrate experimental data with multi-scale computational modelling to establish the rules driving biological response to mechanics and adhesion. With this approach, it aims to explore novel therapeutic approaches beyond the current paradigm in breast cancer treatment. If the partners can understand cancer biomechanics from the single molecule to the whole organ scale, they’ll be able to control mechanical forces to restore healthy cell behaviour and inhibit tumor progression.
Beyond breast cancer, the general principles targeted by this technology will have high applicability in oncology, regenerative medicine, biomaterials and many other biological processes and diseases.
MECHANO·CONTROL is a project funded by the European Commission, within the Future and Emerging Technologies (FET) proactive program.
|Marija Plodinec||CEO Artidis, University Hospital Basel|
|Andrew Ewald||Johns Hopkins University School of Medicine|
|Peter Friedl||Professor, Radboud University Nijmegen, Nijmegen, Netherlands|
|Guillaume Salbreux||Francis Crick Institute|
|Christina Scheel||Institute of Stem Cell Research, Helmholtz Center Munich|
|Buzz Baum||Medical Research Council Laboratory for Molecular Cell Biology at UCL|